Pharvaris N.V. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was EUR 8.49 million compared to EUR 9.14 million a year ago. Basic loss per share from continuing operations was EUR 0.25 compared to EUR 0.28 a year ago.
For the nine months, net loss was EUR 37.14 million compared to EUR 30.39 million a year ago. Basic loss per share from continuing operations was EUR 1.11 compared to EUR 1.03 a year ago.